TrialBMC medicine2026

Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trial.

Jin-Hua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.